Skip to content


Accretropin, Genotropin, Humatrope, Norditropin, Nutropin, Nutropin AQ, Omnitrope, Saizen, Serostim, Zomacton, Zorbtive/Serostim, NutropinAq (somatropin) is a protein pharmaceutical. Somatropin was first approved as Accretropin on 1986-10-16. It is used to treat cachexia, dwarfism, heart failure, noonan syndrome, and prader-willi syndrome amongst others in the USA. It has been approved in Europe to treat pituitary dwarfism, prader-willi syndrome, and turner syndrome. The pharmaceutical is active against growth hormone receptor.
Trade Name NutropinAq
Common Name Somatropin
Indication cachexia, dwarfism, heart failure, noonan syndrome, pituitary dwarfism, prader-willi syndrome, turner syndrome
Drug Class Tricyclic compounds; atropine derivatives; growth hormone derivatives
Get full access now